-
21
Prognostic significance of CDK1 expression in diffuse large B-Cell lymphoma
Published 2025-01-01Subjects: “…Diffuse large B-cell lymphoma…”
Get full text
Article -
22
CD20 Negative Primary Cutaneous Diffuse Large B-Cell Lymphoma, Leg Type with Rapidly Progressing Skin Lesions
Published 2023-09-01Subjects: “…diffuse large B-cell lymphoma, leg type (DLBCL-LT)…”
Get full text
Article -
23
APOC1 knockdown induces apoptosis and decreases angiogenesis in diffuse large B-cell lymphoma cells through blocking the PI3K/AKT/mTOR pathway
Published 2025-01-01Subjects: “…Diffuse large B-cell lymphoma…”
Get full text
Article -
24
Prognostic value of the controlling nutritional status (CONUT) score in patients with diffuse large B-cell lymphoma: a meta-analysis
Published 2025-01-01Subjects: “…Diffuse large B-cell lymphoma…”
Get full text
Article -
25
NCAPD3 promotes diffuse large B-cell lymphoma progression through modulating SIRT1 expression in an H3K9 monomethylation-dependent manner
Published 2025-02-01Subjects: Get full text
Article -
26
A Mitochondria‐Related Signature in Diffuse Large B‐Cell Lymphoma: Prognosis, Immune and Therapeutic Features
Published 2025-01-01Subjects: “…diffuse large B‐cell lymphoma…”
Get full text
Article -
27
Primary central nervous system lymphoma: Comprehension of cell-of-origin subtypes
Published 2023-07-01Subjects: Get full text
Article -
28
-
29
Deregulation mechanisms and therapeutic opportunities of p53-responsive microRNAs in diffuse large B-cell lymphoma
Published 2025-01-01Subjects: “…Diffuse Large B-cell Lymphoma (DLBCL)…”
Get full text
Article -
30
Diffuse large B-cell lymphoma presenting as acute lumbosacral plexopathy with persistent lower back pain and fatigability
Published 2025-01-01Subjects: Get full text
Article